DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Banaschewski T, Johnson M, Lecendreux M et al.
Health-related quality of life and functional outcomes from a randomized-withdrawal study of long-term lisdexamfetamine dimesylate treatment in children and adolescents with attention-deficit/hyperactivity disorder.
CNS Drugs 2014;
DOI: 10.1007/s40263-014-0193-z.
We do not assume any responsibility for the contents of the web pages of other providers.